220
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National Statistics

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-11 | Received 15 Sep 2022, Accepted 16 Dec 2022, Published online: 05 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jetty A Overbeek, Giel Nijpels, Karin MA Swart, Marieke T Blom, Petra JM Elders & Ron MC Herings. (2024) Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020. Diabetes, Metabolic Syndrome and Obesity 17, pages 1503-1509.
Read now

Articles from other publishers (4)

Jakob L. Schroevers, Marieke P. Hoevenaar-Blom, Wim B. Busschers, Monika Hollander, Willem A. Van Gool, Edo Richard, Jan Willem Van Dalen & Eric P. Moll van Charante. (2024) Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands. The Lancet Regional Health - Europe 42, pages 100927.
Crossref
Pauline A J Kiss, Alicia Uijl, Annemarijn R de Boer, Tessa C X Duk, Diederick E Grobbee, Monika Hollander, Elisabeth Smits, Miriam C J M Sturkenboom & Sanne A E Peters. (2024) Sex differences in the intensity of statin prescriptions at initiation in a primary care setting. Heart, pages heartjnl-2023-323722.
Crossref
Karin M. A. Swart, Brenda N. Baak, Louise Lemmens, Fernie J. A. Penning-van Beest, Camilla Bengtsson, Muriel Lobier, Fabian Hoti, Dina Vojinovic, Lindy van Burk, Kirsty Rhodes, Edeltraut Garbe, Ron M. C. Herings, Clementine Nordon & Sami O. Simons. (2023) Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands. Respiratory Research 24:1.
Crossref
Marc G. Vervloet, Hilda JI de Jong, Jan Pander & Jetty A. Overbeek. (2023) Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications. BMC Nephrology 24:1.
Crossref